Literature DB >> 3082038

The in vitro metabolism of aflatoxin B1 catalyzed by hepatic microsomes isolated from control or 3-methylcholanthrene-stimulated rats and quail.

G E Neal, D J Judah, J A Green.   

Abstract

The rate of microsomal metabolism of aflatoxin B1 (AFB1) by the male quail hepatic microsomal polysubstrate monooxygenase P-450 in vitro was eight times greater than that catalyzed by male rat cytochrome. In the quail almost all the metabolism proceeded via 8,9-aflatoxin B1 epoxidation (assessed by Tris-AFB1-8,9-dihydrodiol formation), whereas in the rat only 36% of soluble metabolites were by this pathway. Pretreatment with 3-methylcholanthrene in the quail resulted in a 9-fold induction of cytochrome P-450 per unit liver weight, but only a 1.7-fold increase in the rate of aflatoxin B1 metabolism. In the rat the corresponding inductions were 1.7 and 1.3, respectively. The aflatoxin B1 metabolism catalyzed by control and 3-methylcholanthrene-stimulated quail microsomes differed qualitatively from that observed with the corresponding fractions from the rat. It was concluded that not only do the basal aflatoxin B1 microsomal metabolism of rat and quail differ, but also that 3-methylcholanthrene induces cytochromes with very different properties in the two species. Assays of ethoxyresorufin O-deethylase activities and polyacrylamide gel electrophoresis analyses further demonstrated these differences between the species. These studies provide further insight into the metabolic differences underlying individual species sensitivities to aflatoxin B1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082038     DOI: 10.1016/0041-008x(86)90280-2

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  4 in total

1.  Cyclophosphamide metabolism in the primary immune organs of the chick: assays of drug activation, P450 expression, and aldehyde dehydrogenase.

Authors:  R R Misra; N A Lorr; S E Bloom
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3.

Authors:  Sridevi Bodreddigari; Laundette Knight Jones; Patricia A Egner; John D Groopman; Carrie Hayes Sutter; Bill D Roebuck; F Peter Guengerich; Thomas W Kensler; Thomas R Sutter
Journal:  Chem Res Toxicol       Date:  2008-04-15       Impact factor: 3.739

3.  A system for transformation of rat liver cells in vitro by acute treatment with aflatoxin.

Authors:  S Sinha; L J Hockin; G E Neal
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

4.  Bioactivation and Regioselectivity of Pig Cytochrome P450 3A29 towards Aflatoxin B₁.

Authors:  Jun Wu; Ruohong Chen; Caihui Zhang; Kangbai Li; Weiying Xu; Lijuan Wang; Qingmei Chen; Peiqiang Mu; Jun Jiang; Jikai Wen; Yiqun Deng
Journal:  Toxins (Basel)       Date:  2016-09-12       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.